Veracyte reported $-14129000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acceleron Pharma XLRN:US $ -70.46M 6.94M
Agilent A:US $ 442M 178M
Anika Therapeutics ANIK:US $ 0.56M 5.97M
Arrowhead Research ARWR:US $ -63374000 33.45M
Biocept BIOC:US $ 0.43M 2.26M
Bruker BRKR:US $ 87.1M 29.5M
Dicerna Pharmaceuticals DRNA:US $ -17.07M 23.74M
Exact Sciences EXAS:US $ -166.94M 9.97M
Genmark Diagnostics GNMK:US $ -3.72M 0.5M
Illumina ILMN:US $ 317M 132M
Immunogen IMGN:US $ -37.34M 6.6M
Karyopharm Therapeutics KPTI:US $ -51812000 1.77M
Laboratory Of America LH:US $ 587.3M 119.9M
Ligand Pharmaceuticals LGND:US $ 13.72M 17M
Luminex LMNX:US $ 9.08M 8.84M
Myriad Genetics MYGN:US $ 24.6M 29.3M
Rigel Pharmaceuticals RIGL:US $ -20.95M 7.13M
Sangamo Biosciences SGMO:US $ -47.69M 0.52M
Siemens SIE:GR € 1167M 186M
Sonic Healthcare SHL:AU $ 637.4M 40.23M
Thermo Fisher Scientific TMO:US $ 1902M 74M
Veracyte VCYT:US $ -14.13M 5.09M
Waters WAT:US $ 161.18M 6.11M